RTSN
Retension Pharmaceuticals Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$14.07
+15.23%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- —
- Price / sales
- —
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $110.9M
- EV / sales
- —
- EV / EBITDA
- —
- EV / EBIT
- —
- Market cap
- $110.9M
Trailing, forward and enterprise-value multiples for the requested listing